Zhu Yi-Bing, Lu Pei-Hua, Sheng Zu-Hang
Department of Neurology, Jiao-Tong University School of Medicine, Shanghai 200025, China.
Sheng Li Ke Xue Jin Zhan. 2008 Jan;39(1):5-9.
Alzheimer's disease (AD) is characterized by amyloid beta (Abeta) plaques and neurofibrillary tangles in the brain, reduced synaptic density, and progressive neuronal dysfunction and loss. The elevated levels of the Abeta peptides in brain likely associated to neurodegeneration and cognitive and behavioral abnormalities. While such amyloid mechanism contributes to Alzheimer's pathological conditions, recent studies from a number of laboratories suggest that defective axonal transport may represent an early stage in AD pathogenesis because axonal swellings and reduced axonal transport were observed before apparent AD hallmarks. Here, we overview recent findings that could compromise neuronal abnormalities and provide molecular and cellular insights into the potential mechanisms underlying the defective axonal transport. We also discuss issues to be addressed in future in elucidation of the complex cellular events involved in AD pathogenesis.
阿尔茨海默病(AD)的特征是大脑中存在β-淀粉样蛋白(Aβ)斑块和神经原纤维缠结、突触密度降低以及进行性神经元功能障碍和丧失。大脑中Aβ肽水平升高可能与神经退行性变以及认知和行为异常有关。虽然这种淀粉样蛋白机制导致了阿尔茨海默病的病理状况,但许多实验室最近的研究表明,轴突运输缺陷可能代表了AD发病机制的早期阶段,因为在明显的AD特征出现之前就观察到了轴突肿胀和轴突运输减少。在这里,我们概述了可能导致神经元异常的最新发现,并对轴突运输缺陷潜在机制提供分子和细胞层面的见解。我们还讨论了未来在阐明AD发病机制中涉及的复杂细胞事件时需要解决的问题。